发明名称 PRODUCTION AND THERAPEUTIC USES OF TH1-LIKE REGULATORY T CELLS
摘要 A unique CD4+CD25+ regulatory T cell population develops from naive CD4+CD25- T cells during a TH1 polarized immune response (called TH1-TR cells). These TH1-TR cells can be generated by contacting naïve T cells with mature CD8alpha+ dendritic cells (DCs) that have been exposed to a TH1 polarizing adjuvant and, in some cases, an antigen of interest. The TH1-TR are identified by their expression of the cytokines IL-10 and IFN-gamma, the transcriptional regulators T-bet and FoxP3, and the cell surface molecules CD4, CD25, CD69, CD44 and ICOS.
申请公布号 US2013202628(A1) 申请公布日期 2013.08.08
申请号 US201213665638 申请日期 2012.10.31
申请人 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUN;THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY 发明人 UMETSU DALE;DEKRUYFF ROSEMARIE;AKBARI OMID;STOCK PHILIPPE
分类号 C12N5/0783 主分类号 C12N5/0783
代理机构 代理人
主权项
地址